保誠(02378.HK)與佛山復星禪誠醫院及香港綜合腫瘤中心深化合作
保誠(02378.HK)宣佈,與佛山復星禪誠醫院及香港綜合腫瘤中心達成策略性合作,進一步擴展粵港澳大灣區的跨境癌症治療醫療費用直付服務,配合「共同病患管理」模式提供更便利的跨境醫療無縫銜接服務,滿足區內對優質跨境醫療服務日益增長的需求。
這是保誠與佛山復星禪誠醫院繼5月達成策略性直接合作後,進一步攜手香港綜合腫瘤中心共同推出跨境癌症治療醫療費用直付服務。
佛山復星禪誠醫院與HKIOC將透過「共同病患管理」模式,爲保誠合資格客戶提供多專科會診及個人化的治療計劃,讓他們在這兩間醫療機構接受癌症治療時,均可透過跨專科遠程視頻獲得兩地腫瘤科中心會診服務的支援,並有專屬個案管理團隊全程跟進。
保誠保險香港行政總裁林智剛表示,是次三方強強聯手,是保誠不斷優化以病人爲中心的醫療生態系統的重要里程碑。保誠作爲跨境醫療網絡服務領域的領導者,將繼續秉承以客爲先的服務理念,積極配合大灣區醫療融合發展藍圖,爲客戶提供更多全方位的創新健康保障方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.